New Science Ventures is an institutional investor (Conventional VCs) founded in 2004 and headquartered in New York City, United States. Venture capital firm investing in breakthrough science companies in life sciences and IT. The firm focuses on early and late-stage companies with novel scientific approaches addressing unmet needs. It invests in life sciences and information technology sectors, seeking companies with differentiated value propositions and strong management teams. The firm focuses on fundamental, science-based innovation with strong IP protection, often taking contrarian views and venturing outside traditional tech hubs. They build teams that fit the companies’ stage of development, employing virtual business models. The firm looks for the right investment teams and syndicates, willing to lead, follow, or be sole investors, and are patient, continuing to support their companies through value inflection points.

Stage

early-stage, Series A-D, growth, late-stage, early-stage, Series A-D, growth, late-stage

Check size

$10M-$50M

HQ

New York City, United States

Founded

2004

Website

https://www.newscienceventures.com/

LinkedIn

https://linkedin.com/company/new-science-ventures

Twitter

http://twitter.com/finistereag

What they look for

It invests in life sciences and information technology sectors, seeking companies with differentiated value propositions and strong management teams. The firm looks for the right investment teams and syndicates,...

Preparing to pitch New Science Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.